|
|
| | 2-Propanol, 1-fluoro-3-[[2-[(1E)-4-[6-(methylamino)-3-pyridinyl]-1-buten-3-yn-1-yl]-6-benzothiazolyl]oxy]- Basic information |
| | 2-Propanol, 1-fluoro-3-[[2-[(1E)-4-[6-(methylamino)-3-pyridinyl]-1-buten-3-yn-1-yl]-6-benzothiazolyl]oxy]- Chemical Properties |
| Boiling point | 602.4±65.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | pka | 12.89±0.20(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | 2-Propanol, 1-fluoro-3-[[2-[(1E)-4-[6-(methylamino)-3-pyridinyl]-1-buten-3-yn-1-yl]-6-benzothiazolyl]oxy]- Usage And Synthesis |
| Uses | α-Synuclein aggregate binder 1 (Compound C05-05) is a collective binder and an inhibitor for α-synuclein aggregation. α-Synuclein aggregate binder 1 is utilized in Positron Emission Tomography (PET) imaging and fluorescence microscope, that can diagnose and ameliorate the neurodegenerative disease[1]. | | IC 50 | α-synuclein Aggregation | | References | [1] Higuchi M, et al., Novel α-synuclein aggregate binding agents for disease diagnosis using optical imaging. WO2020174963. |
| | 2-Propanol, 1-fluoro-3-[[2-[(1E)-4-[6-(methylamino)-3-pyridinyl]-1-buten-3-yn-1-yl]-6-benzothiazolyl]oxy]- Preparation Products And Raw materials |
|